WARREN, N.J., Nov. 30, 2011 (GLOBE NEWSWIRE) — MonoSol Rx, LLC (“MonoSol Rx”), the developer of PharmFilm(r) drug delivery technology and a drug delivery company specializing in film pharmaceutical products, announced that the U.S. Food and Drug Administration (FDA) has listed MonoSol Rx’s U.S. Patent No. 8,017,150 in the Orange Book for the Suboxone(r) (buprenorphine HCl and naloxone HCl dihydrate) sublingual film products. (Source: Medical News (via PRIMEZONE))